Literature DB >> 17327468

Functional analysis of the hepatic HMG-CoA reductase promoter by in vivo electroporation.

William R Lagor1, Richard Heller, Eric D de Groh, Gene C Ness.   

Abstract

HMG-CoA reductase (HMGR) catalyzes the rate-controlling step in cholesterol production. This enzyme is highly expressed in the liver, where it is subject to extensive hormonal and dietary regulation. Although much is known about the regulation of the HMGR promoter in cultured cells, this issue has not been directly addressed in liver. The technique of in vivo electroporation was utilized to perform the first functional analysis of the HMGR promoter in live animals. Analysis of a series of deletion constructs showed that deletion of the region containing the cyclic AMP response element (CRE) at -104 to -96 and an NF-Y site at -70 to -65 resulted in marked reduction of promoter activity. Sterol regulation of this promoter was investigated by raising tissue cholesterol levels by feeding cholesterol and by decreasing them through administration of a statin (lovastatin). Using this approach, we found that HMGR promoter constructs were sterol responsive in live animals, adding in vivo relevance to previous findings in cultured cells. We also conclude that in vivo electroporation is a convenient and powerful technique for the analysis of promoter elements in the livers of live animals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17327468

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  10 in total

1.  Involvement of tristetraprolin in transcriptional activation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase by insulin.

Authors:  Gene C Ness; Jeffrey L Edelman; Patricia A Brooks
Journal:  Biochem Biophys Res Commun       Date:  2012-03-03       Impact factor: 3.575

2.  Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport.

Authors:  Shigenori Yamamoto; Hiroyuki Tanigawa; Xiaoyu Li; Yohei Komaru; Jeffrey T Billheimer; Daniel J Rader
Journal:  Circulation       Date:  2011-08-22       Impact factor: 29.690

3.  Peroxisome proliferator activated receptor alpha (PPARalpha) and PPAR gamma coactivator (PGC-1alpha) induce carnitine palmitoyltransferase IA (CPT-1A) via independent gene elements.

Authors:  Shulan Song; Ramy R Attia; Sara Connaughton; Melissa I Niesen; Gene C Ness; Marshall B Elam; Roderick T Hori; George A Cook; Edwards A Park
Journal:  Mol Cell Endocrinol       Date:  2010-08-30       Impact factor: 4.102

4.  Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by thyroid hormone: role of the peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha).

Authors:  Ramy R Attia; Sara Connnaughton; Lindsey R Boone; Fang Wang; Marshall B Elam; Gene C Ness; George A Cook; Edwards A Park
Journal:  J Biol Chem       Date:  2009-11-30       Impact factor: 5.157

5.  In vivo identification of promoter elements and transcription factors mediating activation of hepatic HMG-CoA reductase by T3.

Authors:  Lindsey R Boone; Melissa I Niesen; Mark Jaroszeski; Gene C Ness
Journal:  Biochem Biophys Res Commun       Date:  2009-05-24       Impact factor: 3.575

6.  Overexpression of apolipoprotein F reduces HDL cholesterol levels in vivo.

Authors:  William R Lagor; Robert J Brown; Sue-Anne Toh; John S Millar; Ilia V Fuki; Margarita de la Llera-Moya; Tiffany Yuen; George Rothblat; Jeffrey T Billheimer; Daniel J Rader
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-13       Impact factor: 8.311

7.  Mechanism of resistance to dietary cholesterol.

Authors:  Lindsey R Boone; Patricia A Brooks; Melissa I Niesen; Gene C Ness
Journal:  J Lipids       Date:  2011-10-05

8.  Fat-induced membrane cholesterol accrual provokes cortical filamentous actin destabilisation and glucose transport dysfunction in skeletal muscle.

Authors:  K M Habegger; B A Penque; W Sealls; L Tackett; L N Bell; E K Blue; P J Gallagher; M Sturek; M A Alloosh; H O Steinberg; R V Considine; J S Elmendorf
Journal:  Diabetologia       Date:  2011-10-15       Impact factor: 10.122

9.  Using in vivo electroporation to identify hepatic LDL receptor promoter elements and transcription factors mediating activation of transcription by T3.

Authors:  Dayami Lopez; Patricia A Brooks; Lindsey R Boone; Gene C Ness
Journal:  Appl Transl Genom       Date:  2012-10-03

10.  [18F]Atorvastatin: synthesis of a potential molecular imaging tool for the assessment of statin-related mechanisms of action.

Authors:  Gonçalo S Clemente; Jens Rickmeier; Inês F Antunes; Tryfon Zarganes-Tzitzikas; Alexander Dömling; Tobias Ritter; Philip H Elsinga
Journal:  EJNMMI Res       Date:  2020-04-15       Impact factor: 3.138

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.